THE NEW PROSPECT FOR BODY REGULATION?

Experts are rapidly examining retatrutide, a promising drug developed by Eli Lilly, as a potential advance in weight management. Distinct from many existing approaches, retatrutide is a double -action receptor targeting equally GLP-1 and GIP, hormones that impact satiety and blood glucose regula